146 related articles for article (PubMed ID: 32324983)
1. ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.
Kerwin EM; Spangenthal S; Zvarich M; Millar V; Jain R; Collison K; Sharma R
Chronic Obstr Pulm Dis; 2020 Apr; 7(2):118-129. PubMed ID: 32324983
[TBL] [Abstract][Full Text] [Related]
2. A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD.
van der Palen J; Moeskops-van Beurden W; Dawson CM; James WY; Preece A; Midwinter D; Barnes N; Sharma R
Int J Chron Obstruct Pulmon Dis; 2018; 13():2515-2523. PubMed ID: 30174421
[TBL] [Abstract][Full Text] [Related]
3. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
[TBL] [Abstract][Full Text] [Related]
4. Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.
Collier DJ; Wielders P; van der Palen J; Heyes L; Midwinter D; Collison K; Preece A; Barnes N; Sharma R
Int J Chron Obstruct Pulmon Dis; 2020; 15():1301-1313. PubMed ID: 32606640
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Clinical Trial Comparing the ELLIPTA and HandiHaler Dry Powder Inhalers in Patients With COPD: Inhaler-Specific Attributes and Overall Patient Preference.
Collison KA; Patel P; Preece AF; Stanford RH; Sharma RK; Feldman G
COPD; 2018 Feb; 15(1):46-50. PubMed ID: 29227727
[TBL] [Abstract][Full Text] [Related]
6. First-time handling of different inhalers by chronic obstructive lung disease patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
[No Abstract] [Full Text] [Related]
7. A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
Yun Kirby S; Zhu CQ; Kerwin EM; Stanford RH; Georges G
COPD; 2016; 13(2):167-75. PubMed ID: 26516724
[TBL] [Abstract][Full Text] [Related]
8. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
9. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
[TBL] [Abstract][Full Text] [Related]
10. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler.
Moore AC; Stone S
Int J Clin Pract; 2004 May; 58(5):444-50. PubMed ID: 15206499
[TBL] [Abstract][Full Text] [Related]
11. A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
van der Palen J; Slade D; Rehal S; Verma M; Plank M
Respir Med; 2022 Dec; 205():107031. PubMed ID: 36368290
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
von Schantz S; Katajavuori N; Antikainen O; Juppo A
Int J Pharm; 2016 Jul; 509(1-2):50-58. PubMed ID: 27208655
[TBL] [Abstract][Full Text] [Related]
13. ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.
Kerwin EM; Preece A; Brintziki D; Collison KA; Sharma R
J Allergy Clin Immunol Pract; 2019; 7(6):1843-1849. PubMed ID: 30836228
[TBL] [Abstract][Full Text] [Related]
14. Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.
Siler TM; Jain R; Collison K; Sharma R; Sutton L; Rees J; Bernstein DI
PLoS One; 2022; 17(8):e0273170. PubMed ID: 35969632
[TBL] [Abstract][Full Text] [Related]
15. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
Komase Y; Asako A; Kobayashi A; Sharma R
Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.
Chrystyn H; Price DB; Molimard M; Haughney J; Bosnic-Anticevich S; Lavorini F; Efthimiou J; Shan D; Sims E; Burden A; Hutton C; Roche N
BMC Pulm Med; 2016 Jan; 16():12. PubMed ID: 26769482
[TBL] [Abstract][Full Text] [Related]
17. Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.
Chapman KR; Fogarty CM; Peckitt C; Lassen C; Jadayel D; Dederichs J; Dalvi M; Kramer B
Int J Chron Obstruct Pulmon Dis; 2011; 6():353-63. PubMed ID: 21760722
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Comparison of Two Blister-Type Inhalers.
Kondo T; Tanigaki T; Hibino M; Tajiri S; Horiuchi S; Maeda K; Tobe S
Respir Care; 2023 Mar; 68(3):338-345. PubMed ID: 36100278
[TBL] [Abstract][Full Text] [Related]
19. Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
Man KN; Tian Z; Lam DC; Wan JMF; Tan-Un KC
Int J Chron Obstruct Pulmon Dis; 2018; 13():1949-1963. PubMed ID: 29942127
[TBL] [Abstract][Full Text] [Related]
20. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
Grant AC; Walker R; Hamilton M; Garrill K
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
